Literature DB >> 17650449

Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma.

Mark P Purdue, Qing Lan, Anne Kricker, Claire M Vajdic, Nathaniel Rothman, Bruce K Armstrong.   

Abstract

We studied three vitamin D receptor gene (VDR) polymorphisms (BsmI, TaqI, FokI) in a case-control study of non-Hodgkin's lymphoma. The BsmI B and TaqI t alleles were associated with an increased risk of diffuse large B-cell lymphoma. These findings suggest that variants in VDR may influence lymphomagenesis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17650449     DOI： 10.3324/haematol.11053

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  14 in total

Review 1.  Vitamin D and non-Hodgkin lymphoma risk in adults: a review.

Authors:  Jennifer L Kelly; Jonathan W Friedberg; Laura M Calvi; Edwin van Wijngaarden; Susan G Fisher
Journal:  Cancer Invest       Date:  2009-11       Impact factor: 2.176

2.  Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study.

Authors:  Ellen T Chang; Alison J Canchola; Myles Cockburn; Yani Lu; Sophia S Wang; Leslie Bernstein; Christina A Clarke; Pamela L Horn-Ross
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

Review 3.  Host genetics in follicular lymphoma.

Authors:  James R Cerhan
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-05       Impact factor: 3.020

4.  Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.

Authors:  Jennifer L Kelly; Matthew T Drake; Zachary S Fredericksen; Yan W Asmann; Mark Liebow; Tait D Shanafelt; Andrew L Feldman; Stephen M Ansell; William R Macon; Megan M Herr; Alice H Wang; Grzegorz S Nowakowski; Timothy G Call; Thomas M Habermann; Susan L Slager; Thomas E Witzig; James R Cerhan
Journal:  Cancer Causes Control       Date:  2012-04-28       Impact factor: 2.506

5.  C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients.

Authors:  Tiziana Punzi; Ariele Fabris; Gabriele Morucci; Paolo Biagioni; Massimo Gulisano; Marco Ruggiero; Stefania Pacini
Journal:  Mol Diagn Ther       Date:  2012-04-01       Impact factor: 4.074

6.  Intake of vitamins D and A and calcium and risk of non-Hodgkin lymphoma: San Francisco Bay Area population-based case-control study.

Authors:  Bahar Mikhak; Paige M Bracci; Zhihong Gong
Journal:  Nutr Cancer       Date:  2012-06-14       Impact factor: 2.900

7.  A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.

Authors:  Unhee Lim; D Michal Freedman; Bruce W Hollis; Ronald L Horst; Mark P Purdue; Nilanjan Chatterjee; Stephanie J Weinstein; Lindsay M Morton; Arthur Schatzkin; Jarmo Virtamo; Martha S Linet; Patricia Hartge; Demetrius Albanes
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

8.  Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.

Authors:  Qing Lan; Lindsay M Morton; Bruce Armstrong; Patricia Hartge; Idan Menashe; Tongzhang Zheng; Mark P Purdue; James R Cerhan; Yawei Zhang; Andrew Grulich; Wendy Cozen; Meredith Yeager; Theodore R Holford; Claire M Vajdic; Scott Davis; Brian Leaderer; Anne Kricker; Maryjean Schenk; Shelia H Zahm; Nilanjan Chatterjee; Stephen J Chanock; Nathaniel Rothman; Sophia S Wang
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

9.  Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma.

Authors:  Christoph Renné; Alexander H Benz; Martin L Hansmann
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

10.  Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.

Authors:  Kathrin Klein; Stefan Winter; Miia Turpeinen; Matthias Schwab; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2010-11-02       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.